buyWeak
Chrysa Mineo bought $74k of CDTX
director at Cidara Therapeutics, Inc.. 3,320 shares at an average of $22.26, traded Jun 2, 2025, filed Jun 4, 2025.
Conviction score
31Value
$74k
3,320 shares
Holdings after
3,320
change unknown
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleDirector
- +8Trade size$74k at market
- +8Relative to holdingsFirst purchase: no shares before this trade
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001610618-25-000053, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 2, 2025 | POpen-market purchase Common Stock | +2,270 | $21.71 | $49k | 2,270 | Jun 4, 2025 |
| Jun 3, 2025 | POpen-market purchase Common Stock | +1,050 | $23.44 | $25k | 3,320 | Jun 4, 2025 |
Related signals
Other insiders at Cidara Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 50Moderate | CDTXbuy Cidara Therapeutics, Inc. | Ra Capital Management, L.p. director, owner | $100M 2,272,727 shares | +208% | |
| 29Weak | Cidara Therapeutics, Inc. | Leslie Tari CHIEF SCIENTIFIC OFFICER | $39k 1,773 shares | -10% | |
| 39Weak | Cidara Therapeutics, Inc. | Shane Ward COO & CLO | $37k 1,664 shares | -10% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.